Significant differences between the two groups were observed in the following variables: age, presence of malignant tumors, SOFA score, red blood cell count, hemoglobin levels, aspartate aminotransferase, potassium, creatinine, BUN, albumin, INR, PT, APTT, and vasopressor use (P < 0.05). This evidence concerns the gene ALB and cancer.